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Abstract: Mincle, the macrophage-inducible C-type lectin also known as CLEC-4E, binds 
to the mycobacterial glycolipid trehalose dimycolate and initiates a signaling cascade by 
serving as a receptor for Mycobacterium tuberculosis and other pathogenic mycobacterial 
species. Studies of the biological functions of human mincle often rely on mouse models, 
based on the assumption that the biological properties of the mouse receptor mimic those 
of the human protein. Experimental support for this assumption has been obtained by 
expression of the carbohydrate-recognition domain of mouse mincle and characterization 
of its interaction with small molecule analogs of trehalose dimycolate. The results confirm 
that the ligand-binding properties of mouse mincle closely parallel those of the human 
receptor. These findings are consistent with the conservation of key amino acid residues 
that have been shown to form the ligand-binding site in human and cow mincle. Sequence 
alignment reveals that these residues are conserved in a wide range of mammalian species, 
suggesting that mincle has a conserved function in binding ligands that may include 
endogenous mammalian glycans or pathogen glycans in addition to trehalose dimycolate. 
Keywords: glycan-binding receptor; lectin; mycobacteria 
 
OPEN ACCESS
Molecules 2015, 20 6671 
 
 
1. Introduction 
After many years as an orphan receptor, the macrophage inducible C-type lectin, known as mincle 
or CLEC-4E, has recently been recognized as a receptor for glycans on pathogens [1–3]. It is of 
particular interest because it can bind to trehalose dimycolate, an unusual glycolipid in the outer wall 
of mycobacteria. Mincle is a prototype for a novel subgroup of animal glycan-binding receptors, 
because in addition to containing a Ca2+-dependent carbohydrate-recognition domain (C-type CRD) it 
initiates signaling in macrophages by interacting with the common Fc receptor γ subunit (FcRγ 
subunit) [4]. Binding of Syk kinase to the immunotyrosine activation motifs in the cytoplasmic domain 
of this accessory subunit results in activation of the CARD9 pathway, leading to secretion of 
inflammatory cytokines including interleukin 6 and tumor necrosis factor α [2,4,5]. 
A crystal structure of the CRD from cow mincle provides a structural basis for understanding the 
basis for binding of mincle to trehalose dimycolate [6]. One of the two glucose residues in the 
trehalose headgroup binds in a primary sugar-binding site that resembles that seen in other C-type 
CRDs, in which five amino acid side chains coordinate a Ca2+ and simultaneously four of these 
residues make hydrogen bonds with the 3- and 4-OH groups of the glucose, which is also ligated to the 
Ca2+. A secondary sugar-binding site interacts with the second glucose residue in trehalose and a 
hydrophobic groove next to the primary binding site is proposed to accommodate acyl chains attached 
to the 6-OH group of the glucose residue in the primary binding site. Although structural analysis of 
human mincle has suggested an alternative arrangement of the binding site [7], recent mutagenesis and 
binding studies indicate that the arrangement of the binding site in human mincle is likely to resemble 
closely that seen in the cow structure [8]. 
Important mycobacterial infections in humans include tuberculosis caused by Mycobacterium 
tuberculosis and leprosy caused by M. leprae, while M. bovis is the causative agent of the bovine form 
of tuberculosis [9]. Because of the medical and agricultural importance of these diseases and the 
potential role of mincle in mediating the interaction between macrophages and mycobacteria, the 
structure and mechanism of ligand binding by the cow and human proteins have been studied in detail. 
Although mycobacterial infection is not a common disease of mice, the experimental advantages of 
working with mice have made it a useful model system. An important advantage of working with mice 
is the availability of knock-out mice lacking mincle, FcRγ, and other components of the mincle 
signaling pathway [2,3,10]. In addition, macrophage cell lines from mice, such as RAW 264.7 cells, 
can be used for in vitro studies of mincle [11]. The applicability of the mouse model to understanding 
the role of mincle in human disease depends on the conservation of key properties between the human 
and murine proteins. The studies reported here were undertaken to investigate whether the biochemical 
properties of the human receptor are faithfully replicated by the mouse protein. 
2. Results and Discussion 
2.1. Expression of the CRD from Mouse Mincle 
Mincle is a type II transmembrane protein, in which the CRD lies at the C-terminal end of the 
polypeptide (Figure 1A). The goal of these studies was to characterize binding to the CRD by 
expression of this region as a soluble protein separate from the rest of the polypeptide. In addition, 
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appending a biotinylation tag to the C-terminal end of the polypeptide provides an efficient means of 
immobilization of the CRD to streptavidin-coated plates (Figure 1B). The region of the polypeptide to 
be expressed was selected based on previous studies of human mincle (Figure 1C). A cDNA encoding 
a minimal CRD, which is predicted to contain the three conserved disulfide bonds common to most  
C-type CRDs, was amplified from a full-length mouse mincle cDNA using primers that included the 
consensus biotinylation tag at the C-terminus. 
 
Figure 1. Organization of mouse mincle and expression strategy. (A), Summary of the native 
structure of mincle, containing a short N-terminal cytoplasmic domain, a transmembrane 
domain and a C-terminal CRD separated from the membrane by a short stalk; (B), The 
CRD was expressed in isolation, with a C-terminal biotinylation tag; (C) Comparison of 
the sequence of mouse and human mincle, showing the region of mouse mincle expressed 
in the current work, compared to the previously expressed human protein. The transmembrane 
domain is highlighted in purple, including a basic residue believed to be important for 
interaction with the FcRγ subunit. Six cysteine residues that form three disulfide bonds are 
highlighted in yellow, five amino acid residues that ligate Ca2+ and form the primary 
binding site for one residue of glucose in trehalose are in green, two residues that form  
a secondary binding site for the second glucose residue in trehalose are shown in magenta 
and four residues that are proposed to form a binding site for acyl groups attached to the  
6-OH groups of trehalose are indicated in blue. 
The cDNA was inserted into a vector containing the T7 promoter and co-expressed with the biotin 
ligase gene to ensure efficient attachment of biotin to the lysine residue in the C-terminal tag. Correct 
folding of C-type CRDs requires both formation of the network of disulfide bonds and binding of Ca2+. 
Some C-type CRDs, including the CRD from human mincle, have been expressed directly as folded 
proteins after being directed into the periplasm of bacteria by a prokaryotic signal sequence [12]. In the 
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case of mouse mincle, this strategy did not produce protein in sufficient yield for functional studies, so 
an alternative approach was employed in which the protein was expressed as inclusion bodies in  
the cytoplasm of Escherichia coli. Following solubilization of the denatured protein in guanidine 
hydrochloride, it was refolded by dialysis against Ca2+-containing buffer. The correctly folded protein 
was selectively purified by affinity chromatography on columns of trehalose-Sepharose, prepared by 
divinyl sulfone coupling to achieve a high density of immobilized sugar (Figure 2). The presence  
of some protein in the early fractions suggests that it does not bind tightly to the resin, although  
a significant amount of the protein is retained sufficiently that it elutes in fraction 10, as the  
EDTA-containing buffer emerges from the column. 
 
Figure 2. Purification of mincle CRD by affinity chromatography. Renatured mincle was 
applied to a 10-mL column of trehalose-Sepharose. Following washing with 10 mL of buffer 
containing Ca2+, the column was eluted with EDTA-containing buffer in 1-mL fractions. 
Aliquots (15 μL) of the final fraction collected during the wash (W) along with the elution 
fractions were analyzed by SDS-polyacrylamide gel electrophoresis. Protein was visualized 
by Coomassie blue staining. The expected molecular weight of the CRD with the biotinylation 
tag is 17.8 kDa. 
2.2. Binding of Mouse Mincle to Sugar Ligands 
A solid phase binding competition assay for quantification of the affinity of mouse mincle for 
sugar-containing ligand was developed, based on immobilization of the CRD on streptavidin-coated 
wells. Radioiodinated Man-bovine serum albumin (BSA) was used as a reporter ligand. As shown 
below, simple monosaccharides are not high affinity ligands for the CRD, binding of Man-BSA can be 
detected because at a sugar density of approximately 31 mannose residues per protein molecule,  
the Man-BSA is able to bridge between multiple CRDs immobilized in clusters on the tetrameric 
streptavidin. When working at concentrations of Man-BSA well below saturation binding, inhibition 
constants obtained in this assay will correlate closely with dissociation constants [13]. 
Competition assays comparing α-methyl glucoside and trehalose yielded KI values of 10.3 ± 1.0 mM 
and 0.54 ± 0.18 mM (Figure 3), indicating that mincle binds trehalose with roughly 19-fold higher 
affinity than it binds glucose. This result is very similar to the ratio of 17 obtained for the affinities of 
human mincle for trehalose and α-methyl glucoside [8] although the absolute affinity of mouse mincle 
for trehalose is somewhat higher than for human mincle (KI value of 1.34 ± 0.18 mM). This finding 
suggests the presence of primary and secondary sugar-binding sites in mouse mincle that closely 
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resemble those in the human protein, an interpretation that is consistent with conservation of the 
residues that form both of these sites (Figure 1C). 
 
Figure 3. Competition binding assays comparing binding of simple sugars to mouse 
mincle. Biotin-tagged mincle immobilized in streptavidin-coated wells was probed with 
125I-Man-BSA in the presence of various concentrations of competing ligands. The data 
were fitted to a simple binding equation [14] using a non-linear least squares fitting 
program to determine KI values. Circles represent experimental values, with standard 
deviations for individual data points indicated by error bars, and the fitted curve is shown 
by the solid line. 
In a further comparison with the human form of mincle, the mouse protein was tested for binding to 
a series of acylated derivatives of trehalose that serve as simplified, soluble analogs of the natural 
trehalose dimycolate ligand. These compounds, in which one or both of the 6-OH groups are derivatized 
with short chain fatty acids, were generated using the ability of the lipase from Candida antarctica to 
attach short chain acids selectively to primary alcohol groups under anhydrous conditions [15]. 
Comparison of the KI values for mono-acyl derivatives shows increasing affinity with increasing chain 
length up to 10-fold higher affinity than simple trehalose (Figure 4). A similar trend is observed for the 
di-acyl derivatives and these show significantly enhanced affinity compared to the mono-acyl 
derivatives. This trend, which is both qualitatively and quantitatively similar to that previously seen for 
the human protein [8], has been attributed to the presence of a hydrophobic groove adjacent to the  
6-OH group of the glucose in the primary binding site in the mincle CRD. The hydrophobic character 
of the four aliphatic and aromatic residues that form this groove is conserved in the human and mouse 
proteins (Figure 1C), so the shared ability to bind the glycolipid analogs is consistent with the presence 
of the groove in both proteins. 
A final comparison of the characteristics of human and mouse mincle was made by testing the 
effect of pH on binding. Binding is maximal above pH 7 and falls of in the range between pH 6 and 7, 
so that is it reduced to 10% of maximal binding at the pH of intracellular endocytic compartments such 
as endosomes (Figure 5). Although it has been suggested that mincle probably lacks endocytic activity [2], 
the pH profile is very similar to that seen for other glycan-binding receptors that recycle through 
endosomes [16] and it is interesting that the property is retained across species. 
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Figure 4. Summary of results for mouse mincle binding to mono- and di-acyl derivatives 
of trehalose. Affinities for trehalose derivatives were determined using the competition binding 
assay. The results are expressed as means ± standard deviations, both numerically as KI 
values at the top and graphically as relative affinities compared to trehalose at the bottom. 
 
Figure 5. pH dependence of ligand binding to mouse mincle. Binding of 125I-Man-BSA  
to immobilized CRD from mouse mincle was determined in a series of pH buffers  
formed with a mixture of 25 mM MES and 25 mM MOPS. Data are presented as mean 
values ± standard deviations. A midpoint of approximately pH 6.5 was obtained with  
two independently prepared sets of buffers. 
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2.3. Comparison of Mincle across Species 
Based on the combination of previous structural work on the cow protein and mutagenesis of the 
cow and human proteins, the binding properties have been mapped to specific residues in the CRDs of 
these proteins, and the present study confirms that mouse mincle, in which these same residues are 
present, shows conserved binding properties. The strong similarity in the ligand-binding properties of 
mouse and human mincle suggested that these characteristics might be conserved over a broader range 
of species. A wider survey of mincle conservation was undertaken, comparing all entries in the National 
Center for Biotechnology Information database. A total of 62 different sequences that appear to be 
orthologs of mincle were obtained. Alignment of a selection of these sequences is shown in Figure 6. 
 
Figure 6. Sequence alignment and conservation of key residues in the CRD of mincle 
across species. A selection of the 62 sequences of mincle orthologs spanning a range of 
species is shown. Some of the key conserved framework residues common to C-type CRDs 
are highlighted in yellow, while the residues involved in binding are indicated as green at 
the primary binding site for the first residue of glucose in trehalose, magenta at the secondary 
binding site for the second glucose residue in trehalose and blue at the hydrophobic groove that 
is proposed to form a binding site for acyl groups attached to the 6-OH groups of trehalose. 
In all 62 sequences, there is complete conservation of the residues that form the primary and 
secondary binding sites as well as conservation of the hydrophobic character of the side chains that 
make up the hydrophobic groove in cow mincle. Based on the analysis of mouse mincle presented 
here, in combination with previous work on the human and cow proteins, these findings suggest that 
the binding properties of mincle are likely to be conserved across these species. 
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2.4. Discussion 
Two key findings emerge from this work regarding comparison of the human and mouse proteins 
and conservation of mincle across species. The results provide validation of mouse as a model system 
for studying mincle function in binding trehalose dimycolate. This situation contrasts with the notable 
lack of conservation of ligand-binding properties in some pathogen-binding receptors, such as DC-SIGN 
(dendritic cell-intracellular adhesion molecule 1-grabbing nonintegrin), which is one of two closely 
related receptors in humans, compared to a family of eight closely related genes in mouse, none of 
which encodes a direct ortholog of the human proteins [17]. From an experimental standpoint, this 
result provides a basis for extrapolating results with trehalose dimycolate and its analogs obtained in 
mice, such as the effects of knocking out the mouse gene for mincle, to understanding human biology. 
Of course, the responses mediated by mincle may still differ as a result of other differences in the 
immune system between species. 
Recent studies of mouse and human mincle in macrophages and in transfected cells indicate that 
their interactions with some other types of ligands, such as glycerol monomycolate, differ [18].  
In these experiments, receptors on cells were exposed to surfaces coated with the ligand, so in addition 
to possible differences in affinity of the CRDs for these chemically distinct ligands, the differences 
observed may also be influenced by differences in cell surface density or disposition and interactions 
with other molecules in the plasma membrane. Nevertheless, the results suggest that biochemical 
characterization of the interaction of additional types of ligands with the CRDs from human and mouse 
mincle will be informative. 
The demonstration that conserved sequences correlate with conserved functional properties provide 
a basis for speculation about evolution of mincle function. One important point about the mincle 
sequences that are available is that mincle orthologs are readily identified across mammalian species, 
but not beyond this in birds, reptiles or fish. Such selective radiation of some glycan-binding receptors 
within groups of species has been seen at other levels, such as receptors found in vertebrates but not in 
invertebrates [19]. The results for mincle suggest that it emerged as a mammalian-specific feature of 
the adaptive immune response. A further point about mincle evolution relates to the selective pressures 
that are proposed to drive divergence of the sugar-binding receptors. It has been proposed that rapid 
divergence of receptors such as DC-SIGN and its homologs in different species has resulted from 
exposure of these species to different sets of viruses, bacteria and fungi, so that the receptors are 
adapted in evolutionary time to cope with different pathogens [20,21]. Conservation of ligand-binding 
properties, as suggested by the work reported here, is more commonly associated with receptors that 
bind endogenous mammalian glycans, which would not be subject to such evolutionary pressures. 
There are several potential explanations for the seemingly unusual evolutionary history of the CRD 
in mincle. One possibility is that the mycobacterial threat has been persistent across species, so the 
properties of mincle have been retained. Mycobacterial infections have been reported in a very wide 
range of species, but for the most part these appear to be a result of infection from humans or other 
natural hosts and are not self-sustaining infections except in a few species, such as humans and  
cows [22–24]. It is also notable that such infections have been observed in birds and fish, in which the 
genomes do not seem to encode mincle orthologs. Another possibility is that the conservation of 
mincle reflects binding to other ligands, on widely distributed pathogens or on endogenous 
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glycoproteins or glycolipids, and that the binding of mincle represents an opportunistic exploitation of 
this conserved property of mincle by mycobacterial species. The absence of high affinity binding of 
both human and mouse mincle to panels of mammalian glycans present on the glycan array created by 
the Consortium for Functional Glycomics [25] is more consistent with the idea that mincle targets 
primarily pathogen glycans, but there is also evidence that mincle binds non-glycosylated endogenous 
ligands such as spliceosome-associated protein 130 released from necrotic cells [4]. 
3. Experimental Section 
3.1. Materials 
Sources of material for molecular biology were as follows: a clone of mouse mincle generated by 
the Integrated Molecular Analysis of Genomes and their Expression (IMAGE) Consortium, Clone 
3158063/IRAVp968D122D, with the sequence deposited under accession number BC003218 in the 
National Center for Biotechnology Information database, was obtained from Source BioScience; 
synthetic primers, pCR2.1-TOPO cloning vector from Life Technologies (Glasgow, UK); restriction 
enzymes from New England Biolabs (Hitchin, UK). Trehalose-Sepharose resin for affinity 
chromatography was prepared by divinyl sulfone coupling [26]. Streptavidin-coated polystyrene wells 
for the binding assay were from Thermo Scientific Pierce (Loughborough, UK). Man-BSA, obtained 
from E-Y Laboratories (San Mateo, CA, USA), was iodinated by the chloramine T method 
(Greenwood and Hunter [27]). Synthesis and characterization of acylated trehalose derivatives has 
been previously documented [6]. All of these compounds are soluble in water at levels at least 10-fold 
higher than the concentrations used in the assays. 
3.2. Cloning of cDNA for Mouse Mincle 
The cDNA for expression of mouse mincle was amplified with Advantage 2 polymerase mix 
(Takara Bio, Saint-Germain-en-Laye, France) from the IMAGE clone using forward primer 
aaggatccgatcttggaggatgattaaatggcttgtcctttgaactggaaacattatc, encoding a linker for the expression vector, 
and reverse primer taaagcttctactcatgccactcgattttctgtgcttcgaagatgtcattcagtccgtccagaggacttatttctggc, encoding 
the biotinylation tag. The resulting cDNA was purified by agarose gel electrophoresis and cloned into the 
vector pCR2.1-TOPO (Life Technologies, Glasgow, UK). The sequence was confirmed on an Applied 
Biosystems 310 genetic analyzer (Foster City, CA, USA). The BamH1-EcoR1 insert was excised and 
inserted into the vector pT5T [12,28] for expression under the control of phage T7 RNA polymerase. 
3.3. Expression of Biotin-Tagged CRD 
The expression vector and plasmid pBirA, which encodes biotin ligase and the chloramphenicol 
resistance gene [29], were transformed into E. coli strain BL21(DE3) and were grown in Luria-Bertani 
broth in the presence of 50 μg/mL ampicillin and 20 μg/mL chloramphenicol. A 200-mL starter culture 
grown at 30 °C overnight was used to inoculate 6 L of medium. Growth was continued at 37 °C with 
shaking until an A550 of 0.7 was reached. Isopropyl-β-D-thiogalactoside was added to a concentration 
of 100 mg/liter followed by growth for a further 150 min at 37 °C. Bacteria were harvested by 
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centrifuging at 4000× g for 15 min at 4 °C and were washed by resuspending in 10 mM Tris-HCl, pH 
7.8 and re-centrifuging and the resulting bacterial pellets were stored frozen. 
3.4. Purification of Biotin-Tagged CRD 
Frozen bacterial pellets were thawed, suspended in 30 mL of 10 mM Tris-HCl, pH 7.8, and lysed by 
sonication for four times at full power on a model 250 sonicator (Branson, Danbury, CT, USA) with 
cooling on ice after each 1-min treatment. The insoluble protein was collected by centrifugation at 
10,000× g for 15 min at 4 °C and solubilized by homogenization in 100 mL of 6 M guanidine-HCl 
containing 100 mM Tris-Cl, pH 7.0 and incubated in the presence of 0.01% 2-mercaptoethanol for  
30 min at 4 °C. Following centrifugation for 30 min at 100,000× g, protein was renatured by dialysis 
against 3 changes of 0.5 M NaCl, 25 mM Tris-Cl, pH 7.8, 25 mM CaCl2 at 4 °C. Insoluble material 
was removed by centrifugation for 30 min at 30,000× g. The final supernatant was applied to a 10-mL 
column of trehalose-Sepharose. The column was rinsed with 10 mL of 150 mM NaCl, 25 mM Tris-Cl, 
pH 7.8, 25 mM CaCl2, the bound protein was eluted with 10 mL of 150 mM NaCl, 25 mM Tris-Cl, pH 7.8, 
2.5 mM EDTA. Fractions of 1-mL were collected and aliquots were examined by SDS-polyacrylamide 
gel electrophoresis to identify those containing the CRD. 
3.5. Analytical Methods 
SDS-polyacrylamide gel electrophoresis on 17.5% polyacrylamide gels was performed by the 
method of Laemmli [30]. Streptavidin coated plates were washed once with binding buffer (150 mM 
NaCl, 25 mM Tris-Cl, pH 7.8, 2.5 mM CaCl2) and were coated with biotin-tagged CRDs at 5 μg/mL in 
0.1% (w/v) BSA in binding buffer for 2 h at 4 °C. Wells were washed three times with binding buffer 
before addition of ligands. Serial 3-fold dilutions of competing ligands were prepared in water, after 
which buffer and reporter ligand were added to achieve final concentrations of 0.5 μg/mL 125I-Man-BSA 
and 0.1% BSA in binding buffer. This concentration 125I-Man-BSA is at least 100-fold lower than its 
KD, ensuring that the KI values obtained accurately reflect the affinities of the competing ligands 
independent of the concentration of the reporter ligand [13]. In the pH-dependence assays, buffers 
containing 25 mM 2-(N-morpholino)ethanesulfonic acid and 25 mM 3-(N-morpholino)propanesulfonic 
acid were used in place of the Tris buffer. After incubation for 2 h at 4 °C, wells were washed three 
times with binding buffer and bound radioactivity was measured in a Wallac WIZARD gamma counter 
(PerkinElmer Life Sciences, Beaconsfield, UK). Inhibition constants were obtained using SigmaPlot 
(Systat Software, Hounslow, UK). Values reported are means ± S.D. for 2–3 replicate experiments. 
3.6. Sequence Comparisons 
Potential mincle orthologs were identified in the protein section of the National Center for 
Biotechnology Information database [31] by searching with the terms mincle, CLEC4E, and CLECSF9.  
4. Conclusions 
The results presented here provide evidence that key properties of mincle are conserved between 
mice and humans. Specifically, the interaction of the CRD with acylated trehalose analogs of trehalose 
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dimycolate shows similar specificity and affinity in the binding site. The results are consistent with the 
conservation of amino acid residues that form the ligand-binding site in human mincle as well as the 
cow ortholog. The fact that these residues are conserved across mammalian species suggests that 
mincle has a conserved function in binding this class of ligands. 
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